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A characterization of genes B13R (SPI-2) and B22R (SPI-1) from vaccinia virus strain Western Reserve (WR) is presented. 
These genes are transcribed early during infection and the predicted encoded proteins show similarity to the superfamily 
of serine protease inhibitors (serpins). The 5' transcriptional initiation site of each gene was mapped by primer extension 
experiments to 71-72 and 31 nucleotides upstream of the B13R and B22R open reading frames (ORFs), respectively. Each 
ORF was expressed in Escherichia coil and specific antisera were raised against he protein produced. These antisera were 
used to identify the B13R- and B22R-encoded proteins in vaccinia virus-infected cells as stable, intracellular, nonglycosylated 
proteins of Mr 3&5K and Mr 4OK, respectively. The B22R gene product was detected in all orthopoxviruses tested including 
cowpox, rabbitpox, and vaccinia strains WR, Copenhagen, Tashkent, Tian Tan, Lister, Wyeth, IHD-J, and IHD-W. In contrast, 
the B13R gene product had a more limited distribution and was not detected in Copenhagen, Tashkent, Lister, and Tian 
Tan. Viable virus deletion mutants that lacked only B13R or B22R coding sequences (AB13R and AB22R) and revertant 
viruses in which the deleted gene was restored were constructed by transient dominant selection. The growth of the deletion 
mutants in cell culture was indistinguishable from that of wild-type virus. Additionally the virulence of each deletion mutant 
was indistinguishable from wild-type and revertant viruses in a murine intranasal model. © 1995 Academic Press, Inc. 
INTRODUCTION 
Poxviruses are large, complex viruses that replicate in 
the cytoplasm of infected cells and encode their own 
enzymes for transcription and DNA replication (Moss, 
1992). The 191-kb dsDNA genome of vaccinia virus strain 
Copenhagen has been sequenced and encodes approxi- 
mately 200 genes (Goebel et aL, 1990) of which approxi- 
mately one-third are nonessential for virus replication 
(Johnson et aL, 1993). Several of these nonessential 
genes contribute to virus virulence in vivo and interfere 
with the host response to infection (Smith, 1993). Serine 
protease inhibitors, or serpins, are members of a super- 
family of structurally related proteins. In mammals, many 
serpins are secreted into the plasma where they function 
as inhibitors of the serine proteases involved in the pro- 
cesses of inflammation, complement activation, and 
blood coagulation (Carrell et aL, 1987). In view of this, 
the presence within a number of poxvirus genomes of 
open reading frames (ORFs) with sequence homology to 
serpins (Pickup eta/., 1986; Boursnell eta/., 1988; Tomley 
et a/., 1988; Kotwal and Moss, 1989; Smith et aL, 1989b; 
Upton et aL, 1990; Massung eta/., 1993; Shchelkunov et 
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aL, 1993) is of interest, as it seems likely that the gene 
products may influence virus pathogenesis. 
The most extensively studied orthopoxvirus erpin is 
the cowpox 38K protein (also known as SPI-2 or crmA) 
which has been shown to have several functions. It is 
responsible, at least in part, for the hemorrhagic pock 
phenotype produced on the chorioallantoic membranes 
(CAMs) of fertile hens' eggs by cowpox virus (Pickup et 
al., 1986; Palumbo et aL, 1994) and directly or indirectly 
prevents the migration of white cells in vivo (Palumbo et 
a/., 1989) and in vitro (Chua et aL, 1990). Additionally, it 
inhibits the in vitro processing of pro-interleukin-1/3 (pro- 
IL-1/3) to mature, active IL-1/3 by the pro-lL-1/~ converting 
enzyme (ICE) (Ray et aL, 1992). This may confer the dual 
benefit of reducing release of proinflammatory IL-1/3 and 
inhibiting apoptosis which activated ICE induces in fibro- 
blasts and neuronal cells (Miura et al., 1993; Gagliardini 
et al., 1994). The cowpox 38K protein also restricts the 
formation of a specific leukotriene from the lipoxygenase 
pathway of arachidonic acid metabolism (Palumbo eta/., 
1993, 1994). Both IL-1/~ production and arachidonic acid 
metabolism are important components of the inflamma- 
tory cascade resulting from virus infection. Recently it 
has been shown that deletion of the cowpox 38K protein 
causes attenuation in a murine intranasal model (Thomp- 
son et aL, 1993). 
A further example of the involvement of a poxvirus 
serpin in virus pathogenesis is given by the SERP1 gene 
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of malignant rabbit fibroma virus and myxoma virus (both 
leporipoxviruses) which cause the rapidly fatal, immuno- 
suppressive, systemic infection usually observed in in- 
fected rabbits. Deletion of this gene attenuates both vi- 
ruses (Upton et al., 1990; Macen et aL, 1993). 
Three ORFs with sequence homology to serpins have 
been identified in the Western Reserve (WR) strain of 
vaccinia virus--the prototype orthopoxvirus. These are 
B13R and B22R (previously designated B24R (Smith et 
aL, 1989b)), located near the right end within the Hindlll 
B fragment, and K2L situated near the .left end within 
the Hindlll K fragment. The B13R, B22R, and K2L gene 
products hare 92, 46, and 19% amino acid identity with 
the cowpox 38K protein, respectively. The three WR ORFs 
are transcribed early during infection (Smith et aL, 
1989b), but the encoded proteins have not previously 
been identified. However, it is assumed that K2L is trans- 
lated because a fusion-inhibition phenotype has been 
associated with this gene (Law and Smith, 1992; Turner 
and Moyer, 1992; Zhou et al., 1992). 
In this report, a characterization of the B13R and B22R 
genes of vaccinia virus strain WR is provided. The 5' 
ends of the early transcripts were mapped by primer 
extension, antibodies raised against the ORFs expressed 
in Escherichia coil were used to identify the proteins 
in vaocinia virus-infected cells, the distribution of these 
proteins in other orthopoxviruses was investigated, and 
religated to form pYC15 which contained the intact B13R 
ORF and flanking sequences extending from the middle 
of B12R into B15R. pYC15 was digested with BamHI, end- 
filled with Klenow enzyme, digested with Hpal, and then 
religated. The resultant plasmid, pSK4, had lost an inter- 
nal 926 bp (89%) of the B13R ORF (leaving 110 and 2 
nucleotides at the 5' and 3' ends, respectively). A 1022- 
bp fragment spanning the deleted B13R gene was ex- 
cised from pSK4 by digestion with Xbal and Spel and 
ligated into Xbal-digested pSJH7 (Hughes et al., 1991) 
that contains the E. coil guanine phosphoribosyl trans- 
ferase (Ecogpt) gene under the P7.5 early/late promoter, 
generating pSK5. To make a revertant virus in which the 
mutated B13R gene of the B13R deletion mutant (AB13R, 
see below) was restored to wild type (WT), the intact 
B13 R gene was cloned into pSJH7 by digestion of pYC15 
with Xbal, partial digestion with Spel, and ligation of a 
resultant I948-bp fragment into Xbal-digested pSJH7, 
forming pSK6. 
B22R. pGS120 contains a 3-kb BamHI to Sail fragment 
from the right end of the Sail fragment of vaccinia virus 
strain WR (spanning the B22R gene) cloned into pUC13. 
This 3-kb BamHI to Sail fragment was ligated into 
BamHI- and Sail-digested pSJH7, generating pNWB12. 
pSJH7 was partially digested with Styl, a 7-kb fragment 
was isolated and then digested with Xmalll, end-filled 
with Klenow enzyme, and religated. The resultant plas- 
. . . . . . .  t 920 bp (86%) of the B22R ORF the replication in vitro and virulet Characterization of infectious RYMV cDNA clones es at the 3' end). 
mutants lacking these genes is d 
MATERIALS AND METHODS 
Cells and viruses 
The WR strain of vaccinia virus was used throughout. 
This virus and derivative recombinants were grown on 
BSC-1 cells that were passaged in Dulbecco's modifica- 
tion of minimal essential medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS). Viruses were har- 
vested from infected cells, sedimented through a sucrose 
cushion, and titrated by plaque assay on BSC-1 cells as 
described (Mackett et aL, 1985). 
Plasmid constructions 
Plasmids to be used for isolation bytransient dominant 
selection of virus deletion mutants lacking either the 
B13R or B22R ORFs were constructed as follows. 
B13R. Plasmid pSTH1, containing the right half of the 
vaccinia virus Sail G fragment including most of the B13R 
ORF (Howard, 1991), was digested with Hindlll, treated 
with Klenow enzyme, digested with Sail, and then ligated 
with a 1188-bp fragment derived from the left end of the 
Sail I fragment by Bglll digestion, Klenow treatment, and 
Salt digestio n, forming plasmid pGS124, pGS124 was 
digested with EcoRI and Bglll, treated with Klenow, and 
Primer extension analysis 
Single-stranded DNA primers (25 nucleotides long, 
see Figs. 1B and 10) were 5' labeled with [~,-32p]ATP 
using T4 polynucleotide kinase. Each oligonucleotide 
was then hybridized to RNA extracted from cells infected 
at 15 plaque forming units (PFU) per cell with vaccinia 
virus strain WR early or late during infection or from 
mock-infected cells. Early mRNA was prepared from cells 
6 hr postinfection (hpi) in the presence of 100 #g/ml 
cyclohexamide and late RNA 16 hpi in the absence of 
drugs as previously described (Smith etaL, 1989a). Oligo- 
nucleotide primers were extended with Superscript 
RNase H- reverse transcriptase (Gibco BRL) and the 
radiolabeled DNA analyzed on a 6% polyacrylamide gel 
along side an M13 sequencing ladder. 
Production of polyclonal antisera 
B13R. Two polyclonal rabbit antisera to the B13R pro- 
tein were produced. The first (anti-B13R-1) was raised 
against a /5-galactosidase-B13R fusion protein con- 
taining the C-terminal 74 amino acids of B13R. The Sail 
I fragment of vaccinia virus strain WR cloned in the Sail 
site of pUC9 was digested with Hincll and a 202-bp frag- 
ment purified and cloned into Smal-digested pEX3 (Stan- 
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ley and Luzio, 1984) to form plasmid pEX3-202. E. coil 
POPS 2136 cells transformed with pEX3-202 were grown 
overnight at 30 ° then diluted 1,100 in fresh medium, 
grown at 30 ° for 2 hr, and then expression of the fusion 
protein induced by growth for 1 hr at 42 °. Fusion protein, 
resolved by SDS-PAGE on a 10% gel, was purified by 
electroelution from the gel. New Zealand white rabbits 
were immunized once with 200 #g of fusion protein in 
Freund's complete adjuvant and subsequently at three- 
weekly intervals with 100 #g of fusion protein in incom- 
plete Freund's adjuvant. The second serum (anti-B13R- 
2) was raised against a glutathione S-transferase-B13R 
fusion protein (Smith and Johnson, 1988). A 930-bp 
BamHI-Hpal fragment, containing the B13R ORF without 
the 5' end, was purified from plasmid pYC15 and ligated 
into plasmid pGEX-2T (Smith and Johnson, 1988), which 
had been digested with EcoR1, end-filled with Klenow 
enzyme, and then digested with BamHI. The resultant 
plasmid was called pSK1. The 5' end of the B13R ORF 
was reconstructed using polymerase chain reaction 
(PCR). The PCR product was formed by using oligonucle- 
otides (1) 5'-CCCAGATCTATGGATATC-I-I-CAGG-3' and 
(2) 5'-GAGCGCTAACCq-i-ATCC-3' and pYC15 DNA as 
template. Oligonucleotide (1) represents the beginning 
of the B13R ORF and contains a Bglll site (underlined) 
upstream of the ATG codon. Oligonucleotide (2) is com- 
plementary to an internal region of B13R and crosses 
the BamHI site. The PCR product was digested with Bglll 
and BamHI and ligated into BarnHI-digested pSK1, form- 
ing pSK2. The sequence of the region of pSK2 derived 
by PCR was verified by DNA sequencing. The glutathione 
S-transferase-B13R fusion protein was expressed in E. 
coil strain TG1 transformed with pSK2 by addition of 0.1 
mM IPTG for 4 hr at 37 °. The fusion protein was extracted 
from the bacterial cell pellet by sonication in phosphate- 
buffered saline (PBS) followed by centrifugation (6370 g, 
10 min, 4 °) and subsequently purified by application of 
the soluble fraction to a 2-ml glutathione-Sepharose 4B 
column (Pharmacia) and elution in 5 mM reduced gluta- 
thione, 50 mM Tris-HOl, pH 8. New Zealand white rab- 
bits were immunized subcutaneously with 300 #g of fu- 
sion protein in complete Freund's adjuvant followed by 
similar injections in incomplete Freund's adjuvant at ap- 
proximately four-weekly intervals. 
B22R. A 1.1-kb Styl to Sspl fragment, which includes 
a single nucleotide 5' of the B22R initiation codon and 
47 nucleotides 3' of the termination codon, was purified 
from pGS120 and ligated into the Ndel site of expression 
vector pGMT7 (obtained from M. Chee, MRC, Laboratory 
of Molecular Biology, Cambridge, UK) (Hughes et aL, 
1991). The resultant plasmid, pKL21, was used to trans- 
form E. coil strain BL21 (DE3)/pLysS and the expression 
of the B22R protein induced by addition of 1 mM IPTG. 
The B22R protein was purified in inclusion bodies 
(Hughes et aL, 1991) and then resolved on and excised 
from a 10% polyacrylamide gel. After homogenizing, 100 
#g was administered intramuscularly into rabbits in 
Freund's complete adjuvant followed by subsequent 
boosts in incomplete Freund's adjuvant given at six- 
weekly intervals. 
Immunoblotting 
Monolayers of BSC-1 cells were infected at 10 PFU/ 
cell. At 16 hpi cell monolayers were scraped, collected by 
centrifugation, and resuspended in 200 #1 protein loading 
buffer (Laemmli, 1970). Proteins were resolved by SDS- 
PAGE (10% gel), transferred to a nitrocellulose mem- 
brane (Towbin et aL, t979), and incubated with the poly- 
clonal rabbit anti-B13R-2 serum. For colorimetric detec- 
tion the anti-B13R serum was used at 1..200 dilution. 
Bound immunoglobulin (Ig) was detected by incubation 
with anti-rabbit IgG conjugated to alkaline phosphatase 
(Sigma) followed by reaction with 5-bromo-4-chloro-3-in- 
dolyl phosphate and nitroblue tetrazolium. For detection 
by enhanced chemiluminescence (ECL) (Amersham), the 
anti-B13R serum was used at 1,3000 dilution and bound 
Ig was detected by incubation with anti-rabbit IgG horse 
rabbit peroxidase followed by detection using the ECL 
reagents as described by the manufacturer. 
Immunoprecipitation 
BSC-1 cells were infected with virus at either 30 or 50 
PFU/celI. After 1 hr the virus inoculum was removed and 
the cells were incubated in MEM with 2.5% FBS. At the 
appropriate time thereafter the medium was removed 
and the cells were washed in MEM lacking methionine 
and cysteine and then incubated in the same. After 30 
min the medium was supplemented with 100 #Ci of Trans 
[35S] label (ION Biomedicals, a mixture of approximately 
80% [3~S]methionine and 20% [3~S]cysteine) and incuba- 
tion continued for the appropriate time. The cells were 
then washed in PBS and lysed by the addition of 0.5 rnl 
IP buffer (10 mM Tris-HOl, pH 7.5, 150 mM NaCI, 1% 
sodium deoxycholate, 1% NP-40, 0.1% SDS, i mg/ml BSA, 
0.02% NAN3, and 1 mM PMSF). Cell lysates were cleared 
by centrifugation for 15 min in a microfuge and 200 #1 of 
supernatant was incubated with 10 #1 of 25% (v/v) protein 
A-Sepharose at 4 ° for 2 hr. The protein A-Sepharose 
was removed by tow speed centrifugation and the super- 
natant incubated with 10 #1 polyclonal rabbit anti-serpin 
serum at 4 ° overnight. Immune complexes were collected 
by incubation with 50 #1 protein A-Sepharose for 2 hr 
and then washed three times with IP buffer. Bound pr0- 
teins were resolved by SDS-PAGE (10% gel) and de- 
tected by fluorography. 
Construction of virus deletion mutants and revertants 
Virus deletion mutants lacking the B13R or B22R ORF 
were constructed by transient dominant selection (Falk- 
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her and Moss, 1990) using the Ecogpt gene as the tran- 
sient selectable marker (Boyle and Ooupar, 1988; Falkner 
and Moss, 1988). CV-t cells were infected with vaccinia 
WR strain at 0.01 PFU/cell and transfected with calcium 
phosphate-precipitated pSK5 DNA (for the construction 
of the B13R deletion mutant) or pAB22R DNA (for the 
B22R deletion mutant). Progeny virus harvested 2 days 
later was plated onto BSO-1 cells pretreated for 3 to 12 
hr with 25 #g/ml mycophenolic acid (MPA), 250 ffg/ml 
xanthine, and 15 #g/ml hypoxanthine and then main- 
tained in the presence of these drugs (Boyle and Coupar, 
1988; Falkner and Moss, 1988). Plaque isolates were 
purified two or three times under selection and then three 
times without selection to resolve the MPA-resistant in- 
termediate plaques, producing the deletion mutants and 
sibling WT viruses. Virus isolates were screened by PCR 
and Southern blot analysis and were then amplified and 
purified. The B13R deletion mutant was named 2~B13R 
and the sibling W-i- virus named B13RVVT. Similarly, for 
B22R, the viruses were named AB22R and B22RWT. Re- 
vertant viruses were constructed using transient domi- 
nant selection as described above. For B13R, 0V-1 cells 
were infected with z&B13R at 0.01 PFU/cell and 
transfected with calcium phosphate-precipitated pSK6. 
The MPA-resistant intermediate plaque was resolved to 
produce the original deletion mutant and a revertant virus 
named B13Rrev in which the B13R locus had been re- 
stored to that of WT virus. Similarly for B22R, CV-1 cells 
were infected with 2~B22R and transfected with pNWB 12. 
After the resolution of the MPA-resistant intermediate 
plaque, the virus in which the B22R locus had been re- 
stored was named B22Rrev. The genomic structures of 
allviruses were checked by PCR and Southern blot anal- 
ysis. 
Virulence assay 
Groups of five, 5- to 6-week-old, female, Balb/c mice 
weighing between 15 and 20 g were anesthetized and 
infected intranasally with virus doses ranging from 10 4 
to 106 PFU in 25 #1 of PBS, pH 7.2. Aliquots of the viruses 
used for infection were titrated on BSC-1 cells to confirm 
the dose administered. Animals were individually 
weighed daily. Animals which had lost greater than 30% 
0ftheir original body weight were sacrificed by cervical 
dislocation. 
RESULTS 
Transcriptional analyses 
From inspection of the nucleotide sequence it was 
predicted that ORFs B13R and B22R would be tran- 
scribed at early times during infection (Smith et a/., 
1989b). They are not preceded bythe conserved TAAATG 
m0tiffound at the transcription initiation site of most late 
genes (Rosel et aL, 1986), and there are early transcrip- 
tion termination sequences, TsNT (Yuen and Moss, 1987), 
immediately after B13R and 25 nucleotides before the 3' 
end of B22R. Northern blot analyses of vaccinia mRNA 
had confirmed that these ORFs are transcribed early 
(Smith eta/., 1989b). To more accurately map the 5' ends 
of the B13R and B22R mRNAs, primer extension analyses 
were performed. 
For B13R, extension of the primer (detailed in Fig. 1B) 
produced major extension products of 96 and 97 nucleo- 
tides with RNA extracted from cells early during infection 
but no products were detected with RNA extracted from 
cells late during infection or from mock-infected cells 
(Fig. 1A). Thus it was determined that the B13R early 
mRNA initiates 71-72 nucleotides upstream of the initia- 
tion codon. Sl nuclease protection experiments mapped 
the 5' end of B13R early transcripts to 72-73 nucleotides 
upstream of.the initiation codon (data not shown). For 
B22R, extension of the primer (detailed in Fig. 10) pro- 
duced a major extension product of 72 nucieotides with 
RNA extracted from infected cells early during infection 
but no products were detected with RNA extracted from 
cells late during infection or from mock-infected cells. 
The B22R early mRNA therefore initiates 31 nucleotides 
upstream of the initiation codon (Fig. 10). Each early 
transcript presumably terminates just after a T~NT motif 
which is present either immediately downstream of the 
ORF (B13R) or near the 3' end of the ORF (B22R) to 
produce transcripts of sizes consistent with those deter- 
mined by Northern analysis (Smith et aL, 1989b). 
Identification of the B13R and B22R polypeptides 
To identify the B13R and B22R proteins in vaccinia 
virus-infected cells a rabbit antiserum was raised against 
each of the ORFs expressed in E. coi l  (Materials and 
Methods). Immunoblot analysis (Fig. 2A) using anti-B13R- 
2 serum detected a Mr 38.5K protein in cells infected 
with WR (lane 2) but not in mock-infected cells (lane 
1) nor cells infected with the deletion mutant Z&B13R 
described under Materials and Methods and below (lane 
4). The anti-B22R serum immunoprecipitated a M~ 40K 
protein from cells infected with WR (Fig. 2B, lane 2) but 
not from mock-infected cells (lane 1) nor cells infected 
with the deletion mutant z&B22R (lane 4). In each case 
the serpin was detected in ceils infected with the re- 
vertant virus (Figs. 2A and 2B, lane 5) and in cells infected 
with a plaque-purified W-I-virus isolated by transient 
dominant selection during the construction of the dele- 
tion mutants (Figs. 2A and 2B, lane 3). When the infec- 
tions were repeated in the presence of tunicamycin, an 
inhibitor of N-linked glycosylation, or monensin, an inhibi- 
tor of Q-linked glycosylation and vesicular transport, the 
size of the proteins detected were unaltered indicating 
that these proteins are probably nonglycosylated (data 
not shown). 
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FIG. 1. Primer extension analyses to map the 5' ends of the 813R and B22R mRNAs. (A) RNA extracted from mock-infected cells (M), or from 
cells early (E) or late (L} after infection with vaccinia virus, was hybridized to the a2P-labeled primers detailed in (B) for B13R and (C) for B22R. After 
reverse transcription, the extension products were run on a 6% polyacrylamide gel alongside a sequencing ladder. An autoradiogram is shown. (B) 
Position of the deduced 5' end of the B13R early mRNA (t). The oligonucleotide primer used for extension is underlined. (C) Position of the deduced 
5' end of the B22R early mRNA (O). The oligonucleotide used for reverse transcription is underlined. 
The stability and location of the serpins was analyzed 
by pulse-chase experiments. WR-infected cells were ta- 
beled with [35S]methionine and [35S]cysteine from 2.5 to 
3.5 hpi and then chased for various times up to 24 hpi. 
Cell extracts prepared at these times, or immediately 
after pulse-labeling, were immunoprecipitated with anti- 
BI3R-1 (Fig. 20) or anti-B22R sera (Fig. 2D). These data 
show that each protein is reasonably stable within in- 
fected cells and remains detectable at 24 hpi. Analysis 
of the proteins present in the tissue culture supernatant 
indicated that neither serpin was secreted from the cell 
(data not shown). 
Presence of serpins in other orthopoxviruses 
The presence of the B13R and B22R gene products in 
other orthopoxviruses was investigated by immunobl0t 
analysis for B13R (Fig. 3B) and by immunoprecipitation 
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FiG. 2. (A) Immunoblot analysis of the B13R protein. Monolayers of BSO-t cells were mock-infected (lane 1) or infected with WR (lane 2), B13RVVT 
(lane 3), 2x1313R (lane 4), or B13Rrev (lane 5) at 10 PFU/celh Extracts from cells harvested 16 hpi were resolved on a 10% polyacrylamide gel, 
transferred to nitrocellulose, and reacted with anti-B13R-2-specific serum, and bound Ig was detected using ECL reagents (see Materials and 
Methods). Molecular weights are indicated in kDa. (B) Immunoprecipitation of the B22R protein. BSC-1 monolayers were mock-infected (lane 1) or
infected with WR (lane 2), B22RWT (lane 3), AB22R (lane 4), or 1322Rrev (lane 5) at 30 PFU/cell and labeled with a mixture of [35S]methionine and 
[~S]cysteine b tween 2.5 and 4.5 hpi. Cell lysates were immunoprecipitated with B22R-specific serum, the immunoprecipitates resolved on a 10% 
p01yacrytamide g l and detected by fluorography. Molecular weight markers are hown in kDa (lane M). (C and D) Pulse-chase analysis. BSC-1 
monolayers were infected with WR at 30 PFU/cell and labeled between 2.5 and 3.5 hpi. Lysates were prepared immediately after pulse (lane 1) or 
after chase in GMEM containing 2.5% FBS for 1 (lane 2), 2.5 (lane 3), 4.5 (lane 4), 8.5 (lane 5), and 20.5 hr (lane 6) and immunoprecipitated with 
anti-B13R-1 (C) or anti-B22R (D) serum and then resolved by SDS PAGE on a 10% gel and detected by fluorography. Molecular weight markers 
are shown in kDa. 
for B22R (Fig. 3A). For B13R, a protein of approximately 
Mr 38.5K was detected in cells infected with vaccinia 
virus strains WR and IHD-J, whi le slightly smaller proteins 
were found in cells infected with rabbitpox virus, cowpox 
virus, and vaccinia virus strain Wyeth (Fig. 3B). A protein 
ofthe same size as the IHD-J B13R protein was also 
found in cells infected with IHD-W (data not shown). The 
sequence data for the cowpox virus 38 K gene predicts 
a smaller protein than that in vaccinia virus WR (Pickup 
etaL, 1986; Smith et aL, 1989b). The failure to detect the 
B13R protein in vaccinia virus Copenhagen is consistent 
with published sequence data in which there are dele- 
tions corresponding to the 5' end and an internal region 
0fthe WR ORF that lead to an N-terminal truncation and 
downstream frameshift mutation, respectively (Goebel et 
a/,, 1990; Smith et al., 1991). Given that the B13R protein 
was only detected in cells infected by some of the vi- 
:ruses, it was necessary to show that similar levels of 
virus protein were present in all samples. This was done 
by immunoblotting with B5R-specific antiserum (Engel- 
stad et al., 1992), since the extracellular enveloped virus 
(EEV) gp42 protein encoded by B5R is expressed by all 
the viruses used above (Engelstad and Smith,'1993)(data 
not shown). In contrast to the situation with B13R, a B22R 
protein was expressed by all the orthopoxviruses exam- 
ined (Fig. 3A). 
Construct ion and character izat ion of virus delet ion 
mutants and revertants 
Virus deletion mutants which lack either B13R or B22R 
(AB13R and AB22R) and rever[ant viruses in which the 
gene was reinserted (B13Rrev and B22Rrev) were con- 
structed as described under Materials and Methods. 
During the construction of the deletion mutants by tran- 
sient dominant selection, plaque-purif ied VVT viruses 
(B13RW-I- and B22RWT) were also isolated that are genet- 
ically closer to the deletion mutants than the uncloned 
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WR stock. The genomic structures of these viruses are 
illustrated in Figs. 4 and 5 together with PCR and South- 
ern blotting data confirming their structures. 
Previous experience in our laboratory has shown that 
when the 7.5K promoter driving the Ecogpt gene is in- 
serted into genes within the Hindlll B fragment in the 
same orientation as the native 7.5K gene within the proxi- 
mal inverted terminal repeat (ITR), intramolecular ecom- 
bination events between these copies of the 7.5K pro- 
moter may occur leading to large deletions (S.K., N.W.B., 
and A. AlcamL unpublished data). We have therefore 
used PCR with oligonucleotides that amplify the genes 
to the left and right of the B13R and B22R genes as well 
as the B13R and B22R loci themselves, to ensure that 
the genomes of the recombinant viruses are as expected. 
Figure 4B shows that oligonucleotides from genes B12R 
or B14R amplify the same size fragments from each virus 
(270 or 449 bp, respectively), whereas oligonucleotides 
that span both the B13R and B14R genes produce a WT 
fragment of 1561 bp from WR, B13RWT, and B13Rrev 
viruses, but a smaller fragment of 635 bp from AB13R. 
Similarly, for the B22R viruses (Fig. 5B), PCR products for 
the B21R or B23R genes were the same forall viruses 
(408 and 578 bp, respectively), whereas oligonucleotides 
amplifying the B22R gene produced a fragment of 1148 
bp for WR, B22RWT, and B22Rrev, but a smaller fragment 
of 228 bp for AB22R (Fig. 5B). 
In addition, Southern blotting Sail- or BamHI-digested 
virus DNA with probes that represent he region of B13R 
or B22R deleted in AB13R or AB22R viruses, respec- 
tively (marked z& in Figs. 40 and 50), detected bands of 
the expected sizes with all viruses except the corre- 
sponding deletion mutant where no hybridization was 
detected (Figs. 4A and 5A). Similarly, blotting Sspl- or 
Sail-digested virus DNA with probes from the 3' flanking 
region of the B13R or B22R genes (marked F in Figs. 40 
and 5C) identified fragments of WT size in all viruses 
except the deletion mutants where the band was reduced 
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in size as expected. These data show that the structures 
of the virus genomes were as predicted and no alter- 
ations in the Hindlll B region had arisen other than in 
B13R or B22R genes. 
The isolation of the deletion mutants z&B13R and 
AB22R viruses confirms that B13R and B22R are not 
required for virus replication in vitro (Zhou et al., 1990) 
and is consistent with the observed lack of the B13R 
protein expression in several viruses (above), To more 
aoourately measure the growth properties of WR and the 
deletion mutants, low multiplicity of infection (m.o,i.) (0.01 
PFU/cell) growth curves were performed in BSC-1 cells 
(Figs. 6A and 6B). The results showed that the growth 
kinetics and final titers of the deletion mutants were in- 
distinguishable from WR. 
Vaccinia virus produces two forms of infectious virus, 
intracellular mature virus (IMV) and FEV. EFV represents 
approximately only 1% of total infectious virus with the 
WR strain and, therefore, alterations in EFV formation 
would be masked in measurements of total virus. A sec- 
ond virus growth experiment, this time at high m.o.i. (10 
PFU/celI) was, therefore, undertaken (Figs. 6C and 6D). 
IMV and EEV present within infected cells or in the cul- 
ture supernatant, respectively, at 24 hpi were titrated on 
BSC-1 cells. The loss of either serpin gene did not affect 
the levels of IMV and FEV produced. 
Virulence of delet ion mutants 
The involvement of some orthopoxvirus serpins in virus 
pathogenesis led us to investigate whether vaccinia virus 
144 KEqq-LE ET AL. 
A 
23-  
9.4- 
6.5- 
4.3- 
2.3 -  
2 
M 
C 
BamHI DIGEST SalI DIGEST 
AB22R FLANKING 
PROBE (A) PROBE (F) 
WR 
3 22RWT 
322Rrev 
t._J 
M1 2 3 4 5 6 7 8 9 
S 
I ,, I 
B 
10 11 12 13 
9.8 kb S 
~',\\\\\\~ I I E 'qL-['l 
ID'B 22R"~ ~23 
/ 7 kb 
B 
AB22R 
LJ 
S S 
8.8 kb 
H. 
[, I I I I  IL J  
B21R AB22R B23R 
FIG. 5. Genomic structure of recombinant B22R viruses. (Methods as described in the legend to Fig. 4.) (A) Southern blot analyses, bNA from 
WR, B22RWT, /XB22R, or B22Rrev was digested with BamHI or Sail and probed with the sequence representing the region deleted from the 
endogenous B22R gene (/k) or a fragment from the 3' flanking region of B22R (F). Sizes of the EOL-labeled markers are shown in kb. (B) P0R 
analysis. DNA from WR (lanes 1, 5, and 10), B22RWT (lanes 2, 6, and 1t), AB22R (lanes 3, 7, and 12), or B22Rrev (lanes 4, 8, and 13) was used in 
PCR. Primers used in the analysis were (a) from the 5' and 3' of B21R (lanes 1-4), (b) from ]ust upstream of B22R and the 3' end of B22R (lanes 
5-8), and (c) from the 5' and 3' ends of B23R (lanes 10-13). Lane 9 was a no DNA control with the primers used in lanes 5 8. Sizes of the markers 
are shown in bp. (C) The relevant Sail (S) and BamHI (B) fragments containing the B22R gene (net to scale). The probes used in the Southern blot 
analysis (A and F) as well as the primers used for the PCR analysis (arrows) are shown. The region deleted in /',B22R is represented by a hatohed 
box. 
WR serpins B13R and B22R contribute to virus virulence 
in a murine intranasal model. For these experiments we 
used the plaque-purif ied WT viruses (B13RW-I- and 
B22RWT) that were isolated during the construction of 
the deletion mutants, the deletion mutants (/',B13R and 
/kB22R), and the revertant viruses (B13Rrev and 
B22Rrev). With all viruses, infections at 102 PFU or greater 
caused a rapid and severe weight loss and all animals 
were sacrificed by Day 7 postinfection by which time 
they had lost at least 30% of their body weight (Figs. 7B, 
7C, 7E, and 7F), At 104 PFU there were no differences in 
the amount of weight lost or the rate of recovery between 
mice infected with AB1 3R, B13Rrev, or B13RVVT (Fig. 7A). 
Similarly, there was no difference between /XB22R and 
B22RWT and the slightly greater weight loss of B22Rrev 
was due to a 2.5-fold increased virus input compared to 
the other viruses (Fig. 7D). Overall, these results show 
that deleting B13R or B22R does not attenuate the virus 
in this model system. 
DISCUSSION 
In this paper a characterization of vaccinia virus (WR 
strain) genes B13R and B22R is presented. Transcrip- 
tional analyses showed that early mRNAs initiate 71 to 
72 and 31 nucleotides upstream of the B13R and B22R 
ORFs, respectively. The length of these 5' untranslated 
regions is longer than is the case for many vaccinia 
virus mRNAs but in each case there were no other AUG 
codons between the 5' end of the RNA and the AUG of 1 
the serpin ORF. The sequences upstream of the early 
RNA start sites showed some similarity with the consen- 
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sus for early vaccinia virus promoters (Davison and 
Moss, 1989). 
The proteins encoded by the B13R and B22R ORFs of 
vaccinia virus strain WR were identified as Mr 38.5 and 
40K intracellular polypeptides by the use of specific anti- 
sera raised against bacterially expressed proteins. Each 
protein was stable within the infected cell, was not se- 
creted into the medium, and was not altered by addition 
0fthe glycosylation inhibitors tunicamycin and monensin. 
The B13R gene product was only detected in vaccinia 
virus strains WR, IHD-J, IHD-W, and Wyeth and in rab- 
bitp0x and cowpox and had a slightly reduced size in 
the latter three cases. In contrast, the B22R gene product 
was detected in all strains tested including Copenhagen, 
Tian Tan, Lister, and Tashkent (strains not expressing 
B13R). This distribution may reflect the relative impor- 
tance of the genes in vivo. 
Viable deletion mutants lacking the majority of the 
B13R or B22R ORFs were constructed. Earlier attempts 
to isolate such recombinant viruses by insertion of the 
7.5K promoter-Ecogpt cassette into the serpin loci in 
the same orientation as the 7.5K gene in the proximal 
I-i-R had resulted in large deletions presumably by intra- 
molecular recombination between the duplicated pro- 
moter sequences. Such use of promoters that are re- 
peated in genes which are separated by only nonessen- 
tial genes may reflect a general difficulty in the 
constructien of recombinant poxviruses. Analysis of the 
authentic deletion mutants showed that they had unal- 
tered growth kinetics in vitro and were not attenuated in 
vivo in a murine intranasal model. For B22R the latter 
result is consistent with that reported for deletion mu- 
tants in the corresponding gene of cowpox and rabbitpox 
virus (termed SPI-1) (Thompson et aL, 1993). However, 
for B13R our results differ from those of Thompson et al. 
(1993), who observed striking attenuation when B13R 
was deleted in cowpox and rabbitpox. The reason for 
this discrepancy is unclear, but it may reflect genuine 
differences in the viruses (unlike cowpox and rabbitpox 
the WR virus is highly neurotropic). Alternatively, muta- 
tions might have been acquired elsewhere in the virus 
genomes during the isolation of the cowpox or rabbitpox 
deletion mutants which might explain the difference. The 
production of cowpox or rabbitpox revertant viruses from 
these deletion mutants would address this possibility. 
The function of the B22R serpin is unknown but its 
expression in all orthopoxviruses tested and the conser- 
vation of the gene sequence in two strains of variola 
virus (Massung et al., 1993; Shchelkunov et al., 1993) 
and ectromelia virus (Senkevich et al., 1993) suggests 
it has an important role in orthopoxvirus replication in 
animals. It has been suggested that a role for the vaccinia 
serpins may be to inhibit the cellular proteinases respon- 
sible for the degradation of antigens into peptides for 
presentation to cytotoxic T lymphocytes (CTLs) in associ- 
ation with class I major histocompatibility (MHC) anti- 
gens (Smith etaL, 1989b). This would reduce the presen- 
tation of virus-specific peptides to CTLs and decrease 
the recognition and clearance of infected cells. However, 
recent data suggest that the B13R and B22R serpins of 
vaccinia WR do not block the presentation of several 
influenza virus peptides to class I MHC-restricted CTL 
during infection with vaccinia (unpublished data). None- 
theless the deletion of B13R and B22R from vaccinia 
strain WR potentiated the antibody and CTL responses 
to the human papillomavirus type 16 L1 protein ex- 
pressed by recombinant vaccinia viruses (Zhou et al., 
1990, 1991). 
Several possible functions for the cowpox equivalent 
of the vaccinia virus B13R protein have been proposed 
(see Introduction). Since the B13R protein shares 92% 
amino acid identity with the cowpox protein it would be 
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expected to have similar functions. However, despite the 
presence of a similar B13R gene (38 K, SPI-1, or crmA) 
in both vaccinia and cowpox, during cowpox infection of 
chick CAMs the 38 K protein is a potent inhibitor of the 
inflammatory response (Pickup et aL, 1986; Palumbo et 
al., 1994), while during vaccinia infection there is little or 
no inhibition of the inflammatory response (Palumbo et 
al., 1994). Additionally, deletion of the 38 K serpin from 
cowpox causes attenuation (Thompson et aL, 1993), 
whereas this study shows that deletion of the vaccinia 
serpin B13R does not. Clearly, many different molecules 
and pathways are involved in the host response to virus 
infection and orthopoxvirus pathogenesis is multifacto- 
rial. It may be that the pathways inhibited by the B13R 
protein are less important during vaccinia virus infection 
than during cowpox infection, or vaccinia may encode 
other proteins which inhibit these pathways via an alter- 
native route. 
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